What should you know about mRNA BNT162b2?

The vaccine delivers temporary genetic instructions to some cells. Those cells make a harmless target protein, which prompts immune recognition; the instructions are then broken down. The vaccine does not alter a person’s DNA. BNT162b2 is associated with the Pfizer-BioNTech mRNA vaccine platform, while the exact product available can depend on local recommendations and supply.

Tell the vaccinator about a previous severe allergic reaction to a vaccine ingredient, a past reaction after an mRNA dose, pregnancy, breastfeeding, immune conditions, and medicines that affect immunity. Stay for the observation period advised by the clinic. Soreness at the injection site, tiredness, headache, chills, muscle aches, or fever can occur and often settle with rest and fluids. Use medicines only as advised for you.

Call emergency services for trouble breathing, swelling of the face or throat, collapse, or a rapidly spreading itchy rash after vaccination. Seek prompt medical assessment for chest pain, shortness of breath, or a racing or irregular heartbeat after an mRNA dose. A persistent high fever or symptoms that are worsening also warrant medical advice.

Ask which formulation is being offered, whether your medical history changes the recommendation, how your doses should be scheduled, and which symptoms should prompt urgent review. Ask how vaccination fits with other vaccines or a recent infection.